Moderna Analyst Says Biotech Has 'First-To-Market' Potential For Coronavirus VaccineBenzinga • 05/18/20
Moderna plans to sell more than $1 billion in fresh stock after COVID-19 vaccine study successMarket Watch • 05/18/20
Positive news about Seattle-tested coronavirus vaccine sends stock market sharply higherGeekWire • 05/18/20
Moderna’s encouraging vaccine trial: What we know and why the biggest hurdles are still aheadFast Company • 05/18/20
These 6 Coronavirus Vaccine Candidates Are The Likeliest To Succeed, Says Morgan StanleyBenzinga • 05/18/20
Moderna Reports Positive Results From Early Stage Study of Coronavirus VaccineThe Motley Fool • 05/18/20
Dow futures surge 600 points, adding to Monday gains as Moderna says it sees some success with coronavirus vaccine candidateMarket Watch • 05/18/20
Dow surges nearly 700 points at Monday's open amid hopeful report on Moderna's experimental coronavirus vaccineMarket Watch • 05/18/20
Covid Report: Moderna Vaccine Shows 'Positive' Results In First StudyInvestors Business Daily • 05/18/20
Moderna Rallies On Positive Phase 1 Coronavirus Vaccine Data, Aims For Phase 3 Trial In JulyBenzinga • 05/18/20
Moderna's stock soars on positive early-stage data for its coronavirus vaccine candidateMarket Watch • 05/18/20
Dow futures surge 550 points, adding to Monday gains as Moderna says it sees some success with coronavirus vaccineMarket Watch • 05/18/20
Moderna and Novavax are Making Strides in Advancing Novel Coronavirus Vaccine ResearchThe Motley Fool • 05/16/20
Results From Oxford University's Human Trial Of Coronavirus Vaccine Could Arrive In June; Where Inovio, Moderna StandBenzinga • 05/14/20